Patents by Inventor Joseph W. Wyse

Joseph W. Wyse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER
    Publication number: 20230226188
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 20, 2023
    Applicant: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER
    Publication number: 20200384112
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Application
    Filed: May 1, 2020
    Publication date: December 10, 2020
    Applicant: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • Saposin C pharmaceutical compositions and methods of treating cancer
    Patent number: 10682411
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: June 16, 2020
    Assignee: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER
    Publication number: 20190290764
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Application
    Filed: November 2, 2018
    Publication date: September 26, 2019
    Applicant: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • Active mask variable data integral imaging system and method
    Patent number: 8547524
    Abstract: A system for forming an integral image includes an optics system spaced between an active digital mask and the first side of an integral lens array, where the integral lens array has a light sensitive material layer spaced relative to the second side of the integral lens array. The active digital mask may provide the image directly to the integral lens array, or the image may be focused on a projection screen placed relative to the integral lens array. The active digital mask can vary the provided image to create a three dimensional image and to account for distortions caused by the optics system or curvature in the integral lens array and/or the light sensitive material. Edible materials may be used for the integral lens array and light sensitive material.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: October 1, 2013
    Assignee: Lau Consulting, Inc.
    Inventors: David E. Roberts, Trebor R. Smith, Joseph W. Wyse
  • ACTIVE MASK VARIABLE DATA INTEGRAL IMAGING SYSTEM AND METHOD
    Publication number: 20090207389
    Abstract: A system for forming an integral image includes an optics system spaced between an active digital mask and the first side of an integral lens array, where the integral lens array has a light sensitive material layer spaced relative to the second side of the integral lens array. The active digital mask may provide the image directly to the integral lens array, or the image may be focused on a projection screen placed relative to the integral lens array. The active digital mask can vary the provided image to create a three dimensional image and to account for distortions caused by the optics system or curvature in the integral lens array and/or the light sensitive material. Edible materials may be used for the integral lens array and light sensitive material.
    Type: Application
    Filed: March 21, 2007
    Publication date: August 20, 2009
    Inventors: David E. Roberts, Trebor R. Smith, Joseph W. Wyse
  • Cationic lipid acid salt of 3beta?N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof
    Patent number: 5753262
    Abstract: This invention discloses a novel cationic lipid acid salt of 3.beta.?N-(N',N'-dimethylaminoethane)-carbamoyl!cholesterol. This invention further discloses a transmembrane compatible body suitable for transfection of animals and animal cells with nucleotides such as DNA, RNA, and synthetic nucleotides. Such transmembrane compatible bodies arise from hydratable non-liposomal halogenated solvent-free lyophilate comprising 3.beta.?N-(N',N'-dimethylaminoethane)-carbamoyl!cholesterol and DOPE. This invention yet further discloses a halogenated solvent-free aqueous solution, suitable for lyophilization into a preliposomal powder, wherein the solution comprises 3.beta.?N-(N',N'-dimethylaminoethane)-carbamoyl!cholesterol wherein substantially all 3.beta.?N-(N',N'-dimethylaminoethane)-carbamoyl!cholesterol is dissolved.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 19, 1998
    Assignee: Aronex Pharmaceuticals, Inc.
    Inventors: Joseph W. Wyse, Charles D. Warner